Krystal Biotech is trading at $355.57 (+4.03%) today, with the move appearing to be driven by broader market flow rather than a specific company catalyst.
- The gain comes amid a mixed market backdrop where the biotech sector is showing relative strength, even as broader U.S. equities and technology stocks face risk-off sentiment.
- With no major earnings or regulatory events reported, the move is viewed as an isolated swing within a volatile session rather than a fundamental re-rating of the company.